H. Le Caer

2.2k total citations
49 papers, 819 citations indexed

About

H. Le Caer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, H. Le Caer has authored 49 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 12 papers in Otorhinolaryngology. Recurrent topics in H. Le Caer's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (12 papers) and Head and Neck Cancer Studies (12 papers). H. Le Caer is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (12 papers) and Head and Neck Cancer Studies (12 papers). H. Le Caer collaborates with scholars based in France, Monaco and United States. H. Le Caer's co-authors include C. Chouaïd, A. Vergnenègre, H. Bérard, I. Monnet, H. Léna, P. Fournel, J. Le Treut, G. Robinet, L. Falchero and J.B. Auliac and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Radiotherapy and Oncology.

In The Last Decade

H. Le Caer

47 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Le Caer France 13 555 523 135 133 120 49 819
Barbara Graham Canada 10 795 1.4× 554 1.1× 44 0.3× 113 0.8× 120 1.0× 19 1.0k
N. Bayman United Kingdom 15 753 1.4× 456 0.9× 89 0.7× 131 1.0× 28 0.2× 48 950
P.A. Burt United Kingdom 17 1.0k 1.8× 810 1.5× 145 1.1× 242 1.8× 60 0.5× 48 1.4k
Puja Venkat United States 11 264 0.5× 383 0.7× 52 0.4× 193 1.5× 48 0.4× 36 744
Shervin M. Shirvani United States 17 917 1.7× 318 0.6× 120 0.9× 154 1.2× 148 1.2× 56 1.3k
Franco Vito Piantedosi Italy 12 432 0.8× 519 1.0× 76 0.6× 46 0.3× 124 1.0× 14 698
Christine Ciunci United States 12 671 1.2× 851 1.6× 45 0.3× 121 0.9× 169 1.4× 45 1.1k
Cheryl Pugh United Kingdom 10 970 1.7× 619 1.2× 77 0.6× 124 0.9× 43 0.4× 17 1.1k
Hiroshi Semba Japan 15 962 1.7× 629 1.2× 50 0.4× 127 1.0× 52 0.4× 46 1.1k
N.H. Gower United Kingdom 13 930 1.7× 871 1.7× 217 1.6× 54 0.4× 69 0.6× 17 1.3k

Countries citing papers authored by H. Le Caer

Since Specialization
Citations

This map shows the geographic impact of H. Le Caer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Le Caer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Le Caer more than expected).

Fields of papers citing papers by H. Le Caer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Le Caer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Le Caer. The network helps show where H. Le Caer may publish in the future.

Co-authorship network of co-authors of H. Le Caer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Le Caer. A scholar is included among the top collaborators of H. Le Caer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Le Caer. H. Le Caer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paleiron, N., Radj Gervais, Laurence Gamé, et al.. (2021). Management of patients with synchronous head-and-neck and lung cancers. Journal of Cancer Research and Therapeutics. 18(Suppl 2). S160–S164. 5 indexed citations
2.
Baize, Nathalie, I. Monnet, Laurent Greillier, et al.. (2019). OA15.02 Carboplatin-Etoposide Versus Topotecan as Second-Line Treatment for Sensitive Relapsed Small-Cell Lung Cancer: Phase 3 Trial. Journal of Thoracic Oncology. 14(10). S246–S246. 5 indexed citations
3.
4.
Caer, H. Le, et al.. (2018). Classic biphasic pulmonary blastoma: A case report and review of the literature. Critical Reviews in Oncology/Hematology. 125. 48–50. 8 indexed citations
5.
Ortholan, Cécile, A. Aupérin, C. Mertens, H. Le Caer, & J. Guigay. (2018). Radiothérapie hypofractionnée des cancers ORL chez le sujet âgé. Cancer/Radiothérapie. 22(6-7). 640–643. 5 indexed citations
6.
7.
8.
9.
10.
Guardiola, Emmanuel, et al.. (2013). Experience of multidisciplinary assessment of elderly patients with cancer in a French general hospital during 1year: A new model care study. Journal of Geriatric Oncology. 4(4). 394–401. 15 indexed citations
11.
Bylicki, Olivier, Céline Ferlay, C. Chouaïd, et al.. (2013). Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study. Journal of Thoracic Oncology. 8(7). 906–914. 5 indexed citations
12.
Treut, J. Le, H. Léna, P.-J. Souquet, et al.. (2013). Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. Annals of Oncology. 24(6). 1548–1552. 111 indexed citations
13.
14.
15.
16.
Caer, H. Le, et al.. (2010). Évaluation gériatrique et morbidité après exérèse pulmonaire pour cancer bronchique. Revue des Maladies Respiratoires. 27(5). 483–488. 7 indexed citations
17.
Descourt, R., A. Vergnenègre, Fabrice Barlési, et al.. (2010). Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced Non-small Cell Lung Cancer: The GFPC 05-03 Study. Journal of Thoracic Oncology. 6(2). 351–357. 18 indexed citations
18.
Caer, H. Le, et al.. (2008). Grossesse et cancer du poumon : à propos d’un cas et revue de la littérature. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 37(8). 808–810. 1 indexed citations
19.
Vergnenègre, A., Casey L. Daniel, H. Léna, et al.. (2004). Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. Lung Cancer. 47(3). 395–404. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Graham Breakdown of academic impact, for papers by N. Bayman Breakdown of academic impact, for papers by P.A. Burt Breakdown of academic impact, for papers by Puja Venkat Breakdown of academic impact, for papers by Shervin M. Shirvani Breakdown of academic impact, for papers by Franco Vito Piantedosi Breakdown of academic impact, for papers by Christine Ciunci Breakdown of academic impact, for papers by Cheryl Pugh Breakdown of academic impact, for papers by Hiroshi Semba Breakdown of academic impact, for papers by N.H. Gower
Rankless by CCL
2026